Etiological Factors and Nature of the Active Substance
Examining the etiology of this pathological process requires looking at its primary source. The disease and associated acute conditions develop due to the consumption of specific plant alkaloids. The natural reservoir and source of this compound are the leaves of the shrub botanically named Erythroxylon coca, from which the toxin is extracted.
From a chemical and pharmacological standpoint, the active principle is an organic compound known as benzoylmethylecgonine. Upon entering the human body, this molecule demonstrates a triad of core pharmacological properties that completely determine the clinical picture of intoxication. First, the substance acts as a potent central nervous system stimulant, dramatically altering mental status. Second, it exhibits local anesthetic properties, blocking impulse conduction locally. Third, it acts as an aggressive vasoconstrictor, causing generalized narrowing of blood vessel lumens.
Pathogenesis and Molecular Mechanisms of Damage
The central link in pathogenesis is the profound disruption of normal synaptic function by the toxin. The mechanism of action is based on altering neurotransmitter dynamics. Normally, signal transmission is tightly regulated, but benzoylmethylecgonine causes persistent blockade of the transmembrane transport of biogenic amines into neurons.
The primary hit targets adrenergic nerve fibers. There is marked inhibition of catecholamine reuptake by their terminals. Because neurotransmitters cannot return to the presynaptic terminal, they accumulate in excess within the synaptic cleft, continuously stimulating receptors.
The logical outcome of this molecular disruption is a total and uncontrolled activation of the sympathoadrenal system. It is important to note that when differentiating pathogenetic mechanisms (among which one might mistakenly assume a primary influence on the nigrostriatal, parasympathetic, or hypothalamic-pituitary-adrenal systems), this hyperactivation of the sympathoadrenal link is the true cause of all subsequent systemic disorders.
Clinical Presentation of Acute Use
Even a single exposure to Erythroxylon coca alkaloids provokes striking clinical symptoms that directly result from the pathogenesis described above. The symptom complex of acute use can be divided into psychoemotional and somatic manifestations.
Regarding mental status and subjective sensations, the patient exhibits a sharp improvement in mood and general well-being. This effect is driven by central nervous system stimulation and an excess of biogenic amines.
Somatic manifestations are dictated by sympathoadrenal activation and vasoconstriction:
- A rapid increase in heart rate (HR).
- Concurrently, a sharp rise in blood pressure (BP) is recorded. In clinical practice, this often translates into dangerous hypertensive crises requiring urgent medical intervention.
- Thermoregulation is impaired: an increase in body temperature is noted, which in adverse cases can progress to life-threatening hyperthermia.
Metabolism and Elimination Pathways
Understanding the duration of effects and principles of detoxification requires knowing the metabolic pathways of benzoylmethylecgonine. Once the substance enters the systemic circulation and begins exerting its pathological effects, enzymatic degradation processes are simultaneously initiated.
The main stage of toxin breakdown occurs directly in blood plasma. This reaction is catalyzed by specific enzymes—esterases. Under the action of esterases, the parent molecule is split into metabolites.
The final stage of clearance falls to the excretory system. The breakdown products formed in the blood are transported to the kidneys, filtered, and ultimately excreted in the urine, which is crucial for laboratory confirmation of use.